The efficacy of topiramate in adult refractory status epilepticus: Experience of a Tertiary Care Center

Epilepsy Research

Volumn 98, Issue 2-3, 2012, Pages 232-237

  Synowiec, Andrea S ^a   Yandora, Kristin A ^a   Yenugadhati, Vamsi ^a   Valeriano, James P ^a,b   Schramke, Carol J ^a,b   Kelly, Kevin M ^a,b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Antiepileptic drugs; GABA A receptor; Glutamate receptors; Refractory status epilepticus; Seizures; Topiramate

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; GABAPENTIN; KETAMINE; LAMOTRIGINE; LORAZEPAM; MIDAZOLAM; OXCARBAZEPINE; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DISEASE CONTROL; DRUG DISPOSITION; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG USE; EPILEPTIC STATE; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; STATUS EPILEPTICUS; TIME FACTORS; YOUNG ADULT;

EID: 84856498360     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.09.017     Document Type: Article

References (21)

1. Abend N.S., Dlugos D.J. Treatment of refractory status epilepticus: literature review and a proposed protocol. Pediatr. Neurol. 2008, 38:377-390.
2. Akyildiz B.N., Kumandas S. Treatment of pediatric refractory status epilepticus with topiramate. Childs Nerv. Syst. 2011, 27:1425-1430.
3. Bensalem M.K., Fakhoury T.A. Topiramate and status epilepticus: report of three cases. Epilepsy Behav. 2003, 4:757-760.
4. Blumkin L., Lerman-Sagie T., Houri T., Gilad E., Nissenkorn A., Ginsberg M. Pediatric refractory partial status epilepticus responsive to topiramate. J. Child Neurol. 2005, 20:239-241.
5. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., Garnett L., Fortner C.A., Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46:1029-1035.
6. DeLorenzo R.J., Kirmani B., Deshpande L.S., Jakkampudi V., Towne A.R., Waterhouse E., Garnett L., Ramakrisnan R. Comparisons of the mortality and clinical presentations of status epilepticus in private practice community and university hospital settings in Richmond, Virginia. Seizure 2009, 18:405-411.
7. Jirsch J., Hirsch L.J. Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population. Clin. Neurophysiol. 2007, 118:1660-1670.
8. Kahriman M., Minecan D., Kutluay E., Selwa L., Beydoun A. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia 2003, 44:1353-1356.
9. Logroscino G., Hesdorffer D.C., Cascino G., Annegers J.F., Hauser W.A. Short-term mortality after incident status epilepticus. Epilepsia 1997, 38:1344-1349.
10. Löscher W. Molecular mechanisms of drug resistance in status epilepticus. Epilepsia 2009, 50:19-21.
11. Lowenstein D.H., Alldredge B.K. Status epilepticus. N. Eng J. Med. 1998, 338:970-976.
12. Lowenstein D.H. The management of refractory status epilepticus. Epilepsia 2006, 47:35-40.
13. Niebauer M., Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res. 1999, 873:263-269.
14. O'Neill B.R., Valeriano J.P., Synowiec A., Thielmann D., Lane C., Wilberger J. Refractory status epilepticus treated with vagal nerve stimulation. Neurosurgery 2011, (May 13: Epub ahead of print).
15. Perry M.S., Holt P.J., Sladky J.T. Topiramate loading for refractory status epilepticus in children. Epilepsia 2006, 47:1070-1071.
16. Soler B., Godoy J., Mellado Talesnik P. Treatment of refractory status epilepticus with topiramate: report of three cases. Rev. Med. Chil. 2009, 137:936-939.
17. Suchomelova L., Baldwin R.A., Kubova H., Thompson K.W., Sankar R., Wasterlain C.G. Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. Pediatr. Res. 2006, 59:237-243.
18. Towne A.R., Pellock J.M., Ko D., DeLorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27-34.
19. Towne A.R., Garnett L.K., Waterhouse E.J., Morton L.D., DeLorenzo R.J. The use of topiramate in refractory status epilepticus. Neurology 2003, 60:332-334.
20. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Collins C., Rowan A.J., Handforth A., Faught E., Calabrese V.P., Uthman B.M., Ramsay E., Mamdani M.B. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N. Engl J. Med. 1998, 339:792-798.
21. White H.S., Smith M.D., Wilcox K.S. Mechanisms of action of antiepileptic drugs. Int. Rev. Neurobiol. 2007, 81:85-110.